Concepedia

Joshua J. Oaks

JJ

Statistics

Publications

14

Citations

2.1K

H-Index

13

Active since

2007

Affiliations

Cancer Genetics (United States)(Current)

The Ohio State University

Medical University of South Carolina

Université de Montréal

The University of Texas MD Anderson Cancer Center

Joshua J. Oaks is an author at Cancer Genetics (United States) specializing in molecular oncology, oncology, and life sciences.

Publications per year

2007–2019

14

Publications

14

miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts

Anna M. Eiring, Jason G. Harb, Paolo Neviani et al. · Cell · 2010 · 567 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphocytic leukemia

Paolo Neviani, Ramasamy Santhanam, Joshua J. Oaks et al. · Journal of Clinical Investigation · 2007 · 332 citations · Full text

Medicine, Oncology, Pharmacology +17

Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A‐RIPK1‐dependent necroptosis

Sahar A. Saddoughi, Salih Gencer, Yuri K. Peterson et al. · EMBO Molecular Medicine · 2012 · 265 citations · Full text

Life Sciences, Oncology, Pharmacology +17

PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells

Paolo Neviani, Jason G. Harb, Joshua J. Oaks et al. · Journal of Clinical Investigation · 2013 · 219 citations · Full text

Medicine, Oncology, Pharmacology +16

Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias

Christopher J. Walker, Joshua J. Oaks, Ramasamy Santhanam et al. · Blood · 2013 · 146 citations · Full text

Medicine, Oncology, Pharmacology +10

1–5 of 14